Literature DB >> 25550209

Ezetimibe: rescued by randomization (clinical and mendelian).

Ruth McPherson1, Robert A Hegele2.   

Abstract

Mesh:

Substances:

Year:  2014        PMID: 25550209     DOI: 10.1161/ATVBAHA.114.305012

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  5 in total

Review 1.  Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council.

Authors:  Robert A Hegele; Samuel S Gidding; Henry N Ginsberg; Ruth McPherson; Frederick J Raal; Daniel J Rader; Jennifer G Robinson; Francine K Welty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-09-16       Impact factor: 8.311

2.  Ezetimibe prescriptions in older Canadian adults after an acute myocardial infarction: a population-based cohort study.

Authors:  Kristin K Clemens; Salimah Z Shariff; Eric McArthur; Robert A Hegele
Journal:  Lipids Health Dis       Date:  2018-01-08       Impact factor: 3.876

Review 3.  Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management.

Authors:  Maria Mytilinaiou; Ioannis Kyrou; Mike Khan; Dimitris K Grammatopoulos; Harpal S Randeva
Journal:  Front Pharmacol       Date:  2018-07-12       Impact factor: 5.810

4.  2018 George Lyman Duff Memorial Lecture: Genetics and Genomics of Coronary Artery Disease: A Decade of Progress.

Authors:  Ruth McPherson
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-29       Impact factor: 8.311

5.  Harnessing publicly available genetic data to prioritize lipid modifying therapeutic targets for prevention of coronary heart disease based on dysglycemic risk.

Authors:  Vinicius Tragante; Folkert W Asselbergs; Daniel I Swerdlow; Tom M Palmer; Jason H Moore; Paul I W de Bakker; Brendan J Keating; Michael V Holmes
Journal:  Hum Genet       Date:  2016-03-05       Impact factor: 4.132

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.